Data on the clinical course of lupus anticoagulant (LA)–positive individuals with or without thrombotic manifestations or pregnancy complications are limited. To investigate mortality rates and factors that might influence mortality, we conducted a prospective observational study of LA-positive individuals.
Silvia Koder
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Silvia
Contact Silvia, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack